535 related articles for article (PubMed ID: 33945791)
1. Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation.
Kannt A; Đikić I
Cell Chem Biol; 2021 Jul; 28(7):1014-1031. PubMed ID: 33945791
[TBL] [Abstract][Full Text] [Related]
2. Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System.
Radhakrishnan S; Hoff O; Muellner MK
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500212
[TBL] [Abstract][Full Text] [Related]
3. Ligandability of E3 Ligases for Targeted Protein Degradation Applications.
Belcher BP; Ward CC; Nomura DK
Biochemistry; 2023 Feb; 62(3):588-600. PubMed ID: 34473924
[TBL] [Abstract][Full Text] [Related]
4. E3 ligase ligand chemistries: from building blocks to protein degraders.
Sosič I; Bricelj A; Steinebach C
Chem Soc Rev; 2022 May; 51(9):3487-3534. PubMed ID: 35393989
[TBL] [Abstract][Full Text] [Related]
5. Expanding the ligand spaces for E3 ligases for the design of protein degraders.
Shah Zaib Saleem R; Schwalm MP; Knapp S
Bioorg Med Chem; 2024 May; 105():117718. PubMed ID: 38621319
[TBL] [Abstract][Full Text] [Related]
6. Discovery of E3 Ligase Ligands for Target Protein Degradation.
Lee J; Lee Y; Jung YM; Park JH; Yoo HS; Park J
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235052
[TBL] [Abstract][Full Text] [Related]
7. Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity.
Aminu B; Fux J; Mallette E; Petersen N; Zhang W
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454069
[TBL] [Abstract][Full Text] [Related]
8. Driving E3 Ligase Substrate Specificity for Targeted Protein Degradation: Lessons from Nature and the Laboratory.
Cowan AD; Ciulli A
Annu Rev Biochem; 2022 Jun; 91():295-319. PubMed ID: 35320687
[TBL] [Abstract][Full Text] [Related]
9. Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation.
Maniaci C; Hughes SJ; Testa A; Chen W; Lamont DJ; Rocha S; Alessi DR; Romeo R; Ciulli A
Nat Commun; 2017 Oct; 8(1):830. PubMed ID: 29018234
[TBL] [Abstract][Full Text] [Related]
10. Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation.
Márquez-Cantudo L; Ramos A; Coderch C; de Pascual-Teresa B
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577077
[TBL] [Abstract][Full Text] [Related]
11. Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules.
Hickey CM; Digianantonio KM; Zimmermann K; Harbin A; Quinn C; Patel A; Gareiss P; Chapman A; Tiberi B; Dobrodziej J; Corradi J; Cacace AM; Langley DR; Békés M
Nat Struct Mol Biol; 2024 Feb; 31(2):311-322. PubMed ID: 38177675
[TBL] [Abstract][Full Text] [Related]
12. Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design.
Palomba T; Tassone G; Vacca C; Bartalucci M; Valeri A; Pozzi C; Cross S; Siragusa L; Desantis J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430693
[TBL] [Abstract][Full Text] [Related]
13. An E3 ligase guide to the galaxy of small-molecule-induced protein degradation.
Jevtić P; Haakonsen DL; Rapé M
Cell Chem Biol; 2021 Jul; 28(7):1000-1013. PubMed ID: 33891901
[TBL] [Abstract][Full Text] [Related]
14. Chasing molecular glue degraders: screening approaches.
Domostegui A; Nieto-Barrado L; Perez-Lopez C; Mayor-Ruiz C
Chem Soc Rev; 2022 Jul; 51(13):5498-5517. PubMed ID: 35723413
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis-targeting chimeras (PROTACs) in cancer therapy.
Li X; Pu W; Zheng Q; Ai M; Chen S; Peng Y
Mol Cancer; 2022 Apr; 21(1):99. PubMed ID: 35410300
[TBL] [Abstract][Full Text] [Related]
16. A synthetic KLHL20 ligand to validate CUL3
Farrell BM; Gerth F; Yang CR; Yeh JT
Genes Dev; 2022 Sep; 36(17-18):1031-1042. PubMed ID: 36328355
[TBL] [Abstract][Full Text] [Related]
17. Covalent fragment-based ligand screening approaches for identification of novel ubiquitin proteasome system modulators.
Rothweiler EM; Brennan PE; Huber KVM
Biol Chem; 2022 Mar; 403(4):391-402. PubMed ID: 35191283
[TBL] [Abstract][Full Text] [Related]
18. Targeted Protein Degradation through E2 Recruitment.
Forte N; Dovala D; Hesse MJ; McKenna JM; Tallarico JA; Schirle M; Nomura DK
ACS Chem Biol; 2023 Apr; 18(4):897-904. PubMed ID: 36940189
[TBL] [Abstract][Full Text] [Related]
19. Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.
Ward CC; Kleinman JI; Brittain SM; Lee PS; Chung CYS; Kim K; Petri Y; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Nomura DK
ACS Chem Biol; 2019 Nov; 14(11):2430-2440. PubMed ID: 31059647
[TBL] [Abstract][Full Text] [Related]
20. High throughput E3 ligase degron binding assays for novel PROTAC ligand discovery.
Guenette RG; Potts PR
Methods Enzymol; 2023; 681():23-39. PubMed ID: 36764759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
